Drug Development Stocks List

Recent Signals

Date Stock Signal Type
2021-02-24 ABCL Slingshot Bearish Bearish Swing Setup
2021-02-24 ABCL Stochastic Buy Signal Bullish
2021-02-24 ABCL Narrow Range Bar Range Contraction
2021-02-24 ABCL NR7 Range Contraction
2021-02-24 ALGS NR7 Range Contraction
2021-02-24 ALGS Fell Below 20 DMA Bearish
2021-02-24 AMPH Slingshot Bearish Bearish Swing Setup
2021-02-24 AMPH Lower Bollinger Band Walk Weakness
2021-02-24 ATHA Pocket Pivot Bullish Swing Setup
2021-02-24 ATHA 20 DMA Support Bullish
2021-02-24 AYLA NR7 Range Contraction
2021-02-24 AYLA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 AYLA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 AYLA Narrow Range Bar Range Contraction
2021-02-24 AYLA NR7-2 Range Contraction
2021-02-24 BTAI Crossed Above 20 DMA Bullish
2021-02-24 CDXS Stochastic Reached Oversold Weakness
2021-02-24 CERT 20 DMA Resistance Bearish
2021-02-24 CLSN Calm After Storm Range Contraction
2021-02-24 CSBR Crossed Above 20 DMA Bullish
2021-02-24 ENZ Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 HSAQ NR7 Range Contraction
2021-02-24 HTGM Fell Below 50 DMA Bearish
2021-02-24 ITCI Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 ITCI NR7 Range Contraction
2021-02-24 LDOS New Downtrend Bearish
2021-02-24 LDOS Lower Bollinger Band Walk Weakness
2021-02-24 NTEC 200 DMA Resistance Bearish
2021-02-24 NTEC NR7 Range Contraction
2021-02-24 NTEC Narrow Range Bar Range Contraction
2021-02-24 NTEC Stochastic Reached Oversold Weakness
2021-02-24 NTEC 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 NTEC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 PPD 50 DMA Support Bullish
2021-02-24 PPD Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 PPD Fell Below 20 DMA Bearish
2021-02-24 PPD MACD Bearish Signal Line Cross Bearish
2021-02-24 PPD Wide Range Bar Range Expansion
2021-02-24 PTN Crossed Above 50 DMA Bullish
2021-02-24 PTN Calm After Storm Range Contraction
2021-02-24 RIGL 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 RIGL Crossed Above 20 DMA Bullish
2021-02-24 RIGL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 RPRX Pocket Pivot Bullish Swing Setup
2021-02-24 RPRX 20 DMA Resistance Bearish
2021-02-24 RPRX Bollinger Band Squeeze Range Contraction
2021-02-24 SRRA Stochastic Buy Signal Bullish
2021-02-24 SRRA Narrow Range Bar Range Contraction
2021-02-24 SRRA Slingshot Bearish Bearish Swing Setup
2021-02-24 SWTX New 52 Week Closing High Bullish
2021-02-24 TYME Narrow Range Bar Range Contraction

Recent News for Drug Development Stocks

Date Stock Title
Feb 25 CDXS Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Feb 25 SWTX SpringWorks’ mid-stage neurofibromatosis trial shows 50% objective response rate
Feb 25 BTAI BioXcel Therapeutics Starts Testing BXCL501 In Mid-Stage Delirium-Related Agitation Study
Feb 25 CLSN Celsion's Ovarian Cancer Immunotherapy Shows 38% Improvement In R0 Resection Rates Versus Control Arm
Feb 25 CLSN Celsion gives update on Phase I/II GEN-1 ovarian cancer study
Feb 25 CLSN Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores
Feb 25 SWTX SpringWorks Therapeutics Shows Early Action In Peripheral Nerves Tumor Study
Feb 25 LDOS DTRA Awards Leidos Project to Conduct Clinical Trials for COVID-19 Therapeutics
Feb 25 LDOS Leidos Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm
Feb 25 ITCI Intra-Cellular Therapies EPS beats by $0.09, beats on revenue
Feb 25 CLNN Clene Nanomedicine Presents Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021
Feb 25 ITCI Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update
Feb 25 BTAI BioXcel starts mid-stage BXCL501 trial for treatment of delirium related agitation
Feb 25 BTAI BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related Agitation
Feb 25 SWTX SpringWorks Therapeutics EPS beats by $0.31, beats on revenue
Feb 25 SWTX SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Feb 25 SWTX SpringWorks Therapeutics Reports Interim Data from Phase 2b ReNeu Trial of Mirdametinib for Patients with NF1-PN and Provides Trial Update
Feb 25 BTAI BTAI: Highlights from BXCL501 KOL Event…
Feb 25 PPD PPD, Inc. (PPD) CEO David Simmons on Q4 2020 Results - Earnings Call Transcript
Feb 25 LDOS LEIDOS HOLDINGS ALERT: Bragar Eagel & Squire, P.C. is Investigating Leidos Holdings, Inc. on Behalf of Leidos Stockholders and Encourages Investors to Contact the Firm